Researchers develop artificial intelligence tool for automatic colorectal cancer tissue analysis

NewsGuard 100/100 Score

Researchers from the University of Jyväskylä in collaboration with the Institute of Biomedicine University of Turku and Nova Central Finland have developed an artificial intelligence tool for automatic colorectal cancer tissue analysis. The refined neural network outperformed all previous solutions in the task. The neural network offers a faster, more precise method for classifying colorectal cancer tissue images from microscope slides. This could significantly reduce the workload of histopathologists, leading to quicker insights, prognoses, and diagnoses.

Public accessibility for future advancements

In a significant nod to open science and cooperative growth, the researchers are making the trained neural network tool available to the public. This gesture is intended to spur further advancements by inviting scientists, researchers, and developers globally to refine its capabilities and investigate new applications.

"By granting universal access, the aim is to fast-track breakthroughs in colorectal cancer research", adds Fabi Prezja, who was responsible for the design of the method.

Stringent clinical validation is imperative

While the results are promising, it's crucial to adopt AI in clinical settings judiciously. The calibre and diversity of medical data are central to the success of AI-driven methods. As these AI solutions inch closer to routine clinical implementation, it's imperative they undergo stringent clinical validation to ensure their outcomes consistently align with clinical standards.

Source:
Journal reference:

Prezja, F., et al. (2023). Improved accuracy in colorectal cancer tissue decomposition through refinement of established deep learning solutions. Scientific Reports. doi.org/10.1038/s41598-023-42357-x.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aspirin shows no benefit in preventing breast cancer recurrence, study finds